ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintTitle ChevronIcon Twitter
International relations

Duterte threatens to end US military pact if no vaccines

Philippine leader pressures Washington after procurement delays

President Rodrigo Duterte has threatened to send home U.S. forces stationed in the Philippines as his government's COVID-19 vaccine plans fall into disarray. (Photo courtesy of Presidential Communications Operations Office)

MANILA -- President Rodrigo Duterte has threatened the U.S. that the Philippines will end a key military agreement if millions of vaccines against COVID-19 are not delivered.

Facing strong domestic criticism over procurement delays, Duterte has tried to turn the Visiting Forces Agreement into a bargaining chip to secure COVID-19 vaccines from the U.S.

"If they fail to deliver a minimum of 20 million vaccines, they better get out -- no vaccine, no stay here," the president said on Saturday during a televised meeting with members of his cabinet and the national COVID-19 task force.

In November, Duterte agreed to extend by six months a 1998 agreement on the entry of U.S. troops that is critical to Manila's mutual defense treaty with Washington. The president had unilaterally abrogated the agreement earlier in the year.

Duterte's threat comes with his administration taking fire for failing to seal a vaccine deal with Pfizer, while Southeast Asian neighbors such as Singapore and Indonesia progress towards deliveries.

Earlier this month, Foreign Affairs Secretary Teodoro Locsin Jr. said Manila had secured 10 million doses of Pfizer vaccine with the help of U.S. Secretary of State Mike Pompeo. The vaccine would have been ready for shipment in January 2021 but the deal fell through after Health Secretary Francisco Duque supposedly "dropped the ball."

However, Duque denied the allegation and said there had never been a firm commitment from the U.S. pharmaceutical giant.

On Saturday, Duterte lent support to Duque and lashed out at the U.S. "Do not believe in that shit about America that they can deliver immediately," he said. "I've been with government -- I have dealt with them many times."

In July, with Filipinos reeling from one of the world's longest lockdowns, Duterte called for patience and expressed the hope that the country would be "back to normal" by December with vaccines becoming available.

The Philippine president previously favored vaccines from China and Russia, slamming "Western counties" for being "all profit, profit, profit."

So far, the Philippines has secured only 2.6 million doses from the U.K.'s AstraZeneca, and those are due to start delivery by May when inoculations are also expected to start. The vaccines were ordered by leading Philippine companies that have promised to donate half the doses to the government.

Officials have said that deals with other pharmaceutical companies are in the works and contracts might be signed early next year. Pfizer has also applied for emergency use permission in the Philippines, officials said.

So far, the Philippines has confirmed nearly 470,000 COVID-19 cases -- one of the highest figures in Southeast Asia -- with over 9,000 deaths.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends January 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more